ICLE to Bring Together Experts in Lymphocyte Engineering

Milan, Italy – June 2026

ICLE 2026, the 6th International Conference on Lymphocyte Engineering, will take place on 15-17 July 2026 at the San Raffaele Congress Center in Milan, Italy, bringing together the world’s leading researchers, clinicians, and industry professionals working across gene, cell, and immune therapies. 

The Conference will focus on real-world experience, novel clinical approaches and combination therapies, CAR/TCR mRNA therapies, in vivo T-cell engineering, advanced TCR engineering, and more, offering a comprehensive scientific and professional program that reflects the latest developments and future directions in the field. 

Participants will benefit from: 

  • Keynote lectures, plenary sessions and poster presentations from the world’s leading experts, covering the latest developments in this rapidly evolving field 
  • Unique session formats for early career professionals, including “The Researcher’s Journey” and “Expert-Led Inspiration” 
  • Cutting-edge scientific and clinical insights that bridge the gap between research and real-world application 
  • Meaningful collaboration and professional growth, empowering the global community to translate innovation into future medical breakthroughs 

At a time when scientists and clinicians are redefining how we treat cancer and immune diseases by engineering the body’s own cells, ICLE stands at the forefront of this transformation,said Prof. Adi Barzel, ICLE Co-Chair and President of the Israeli Society for Gene and Cell Therapy.ICLE is the top conference for scientists and physicians who are interested in the engineering of lymphocytes for the therapy of cancer, autoimmune disease and beyond. 

ICLE is a Kenes Original Event, developed and organised by Kenes Group as part of its growing portfolio of proprietary conferences dedicated to advancing key professional fields. 

ICLE is expected to welcome hundreds of international expert researchers and clinicians, strengthening collaboration across the field and supporting the continued advancement of lymphocyte engineering. 

Media and Registration Information 

For more information, including registration details and the scientific program, visit:
https://lymphocyte.kenes.com/  

Media contact:

Ivan Simeonov
isimeonov@kenes.com
+41 22 908 0488 Ext. 264